Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | IBER | PYXS | MDWD | ||
Company | Ibere Pharmaceuticals Cl A | Pyxis Oncology Inc | Mediwound Ltd Ord Sh | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 10.18 | 3.54 | 19.15 | ||
High | 10.18 | 3.74 | 19.72 | ||
Low | 10.18 | 3.35 | 18.69 | ||
Last | 10.18 | 3.69 | 19.19 | ||
Change | -0.03 | +0.21 | +0.59 | ||
% Change | -0.29% | +6.03% | +3.17% | ||
Volume | 44,400 | 509,300 | 81,900 | ||
20-Day Average Volume | 61,365 | 962,470 | 397,200 | ||
Previous Close | 10.21 | 3.48 | 18.60 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 10.17 | 3.16 | 18.00 | ||
20-Day Raw Stochastic | 5.79% | 94.62% | 54.24% | ||
20-Day Relative Strength | 62.60% | 54.56% | 54.85% | ||
Weighted Alpha | +5.10 | -10.13 | +90.58 | ||
Today's Opinion | 100% Buy | 16% Sell | 100% Buy | ||
Previous Opinion | 100% Buy | 40% Sell | 100% Buy | ||
Last Month's Opinion | 100% Buy | 24% Sell | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.10% since 02/17/23 | +15.31% since 07/15/24 | -5.98% since 07/15/24 | ||
Low | 10.17 on 02/21/23 | 3.17 on 07/18/24 | 18.49 on 07/19/24 | ||
High | 10.21 on 02/28/23 | 3.74 on 07/22/24 | 21.02 on 07/18/24 | ||
1-Month | |||||
%Chg | +0.20% since 02/01/23 | +9.50% since 06/21/24 | +42.57% since 06/21/24 | ||
Low | 10.15 on 02/06/23 | 2.81 on 07/09/24 | 13.49 on 06/24/24 | ||
High | 10.75 on 02/06/23 | 3.74 on 07/22/24 | 24.00 on 07/05/24 | ||
3-Month | |||||
%Chg | +1.50% since 11/30/22 | -18.54% since 04/22/24 | +21.76% since 04/22/24 | ||
Low | 10.03 on 12/02/22 | 2.81 on 07/09/24 | 12.78 on 06/21/24 | ||
High | 10.75 on 02/06/23 | 4.78 on 05/03/24 | 24.00 on 07/05/24 | ||
6-Month | |||||
%Chg | +3.25% since 09/01/22 | +44.71% since 01/22/24 | +42.25% since 01/22/24 | ||
Low | 9.87 on 09/02/22 | 2.59 on 01/23/24 | 11.04 on 02/06/24 | ||
High | 10.75 on 02/06/23 | 6.85 on 02/27/24 | 24.00 on 07/05/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 175,605 | 204,930 | 172,675 | ||
Shares Outstanding, K | 17,250 | 58,888 | 9,284 | ||
Annual Sales | 0 | 0 | 18,690,000 | ||
Annual Net Income | 1,560,000 | -73,790,000 | -6,720,000 | ||
Last Quarter Sales | 0 | 16,150,000 | 4,960,000 | ||
Last Quarter Net Income | 789,819 | -3,260,000 | -9,730,000 | ||
60-Month Beta | 0.00 | 1.28 | 0.81 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.06 on 11/14/22 | -0.06 on 05/14/24 | -0.39 on 05/29/24 | ||
Latest Earnings Date | 03/06/23 | 08/09/24 | 08/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |